Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Microbot Medical Inc. (NASDAQ: MBOT)
MBOT Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-10.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
68.30%
MBOT Stock Analysis
MBOT
PE Ratio:
MBOT
PEG Ratio:
Not Available
MBOT
Forward EPS Growth (12 month):
0.00%
MBOT
PS Ratio:
855
MBOT
PSG Ratio:
7.3
MBOT
Forward Revenue Growth (12 month):
116.40%
MBOT Articles
No data was found